Latest News - ResMed
Top Corporates Hub
ResMed
Seeking Clues to ResMed (RMD) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics
29.10.2025 13:15
Besides Wall Street's top-and-bottom-line estimates for ResMed (RMD), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2025.
ResMed (RMD) Reports Q3: Everything You Need To Know Ahead Of Earnings
29.10.2025 03:03
Medical device company ResMed (NYSE:RMD) will be reporting earnings this Thursday afternoon. Here’s what investors should know.
Do Options Traders Know Something About ResMed Stock We Don't?
27.10.2025 14:33
Investors need to pay close attention to RMD stock based on the movements in the options market lately.
Home Healthcare Market Research Report 2025-2030: Leading Companies are Innovating and Introducing New Home Healthcare Products to Gain a Competitive Advantage
21.10.2025 09:22
The global home healthcare market is projected to reach USD 473.8 billion by 2030, up from USD 309.9 billion in 2025, growing at a CAGR of 8.9%. This expansion is driven by rising lifestyle-related disorders such as high blood pressure, obesity, and cardiac conditions. Leading companies are innovating and introducing new home healthcare products. The therapeutic products segment holds the largest market share, fueled by a growing prevalence of chronic health conditions. Skilled nursing services
PolyNovo (ASX:PNV): Valuation Perspectives Following Board Appointment of ResMed Veteran Robert Douglas
21.10.2025 03:09
PolyNovo (ASX:PNV) has appointed Robert Douglas to its Board of Directors, a move that brings decades of international medical device leadership into the mix. Investors are tuning in to see what his experience could mean for PolyNovo’s strategic direction. See our latest analysis for PolyNovo. PolyNovo’s recent board appointment arrives just as its share price faces volatility, slipping 20% over the past month and down nearly 39% year-to-date. Longer-term shareholders have felt the pressure...
4 GARP Stocks That Investors Can Scoop Up for Maximum Returns
17.10.2025 14:49
Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. SYK, NVDA, RMD and RL hold promise.
2 Unpopular Stocks That Deserve a Second Chance and 1 That Underwhelm
17.10.2025 04:36
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.
Abbott (ABT) Q3 Earnings Meet Estimates
15.10.2025 12:40
Abbott (ABT) delivered earnings and revenue surprises of 0.00% and -0.24%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Saudi Arabia $5.94 Bn Sleep Apnea Devices Market Trends, Competition, Forecast & Opportunities, 2030F Featuring ResMed, Philips, Invacare, Itamar Medical, and Nihon Kohden
07.10.2025 14:00
The Saudi Arabia Sleep Apnea Devices Market offers growth opportunities driven by rising OSA awareness and demand for diagnostic and therapeutic technologies. Key trends include integrating digital health tools and remote monitoring. Expanding hospital and homecare use highlights the market potential amidst challenges like low public awareness. Saudi Arabian Sleep Apnea Devices Market Saudi Arabian Sleep Apnea Devices Market Dublin, Oct. 07, 2025 (GLOBE NEWSWIRE) -- The "Saudi Arabia Sleep Apnea
What to Expect From ResMed's Next Quarterly Earnings Report
07.10.2025 12:04
ResMed is expected to release its fiscal first-quarter earnings soon, and analysts project a double-digit earnings growth.
2 Safe-and-Steady Stocks with Exciting Potential and 1 That Underwhelm
07.10.2025 04:34
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.
Align Technology, ResMed, Insulet, Envista, and Dentsply Sirona Shares Plummet, What You Need To Know
25.09.2025 17:06
A number of stocks fell in the afternoon session after the U.S. Commerce Department initiated a national security investigation into medical equipment and devices, raising concerns about potential tariffs.
Anesthesia and Respiratory Devices Global Markets Report 2025-2030, Profiles of Prominent Players - F. Hoffmann-La Roche, Koninklijke Philips, ResMed, Teleflex, GE Healthcare, and Medtronic
25.09.2025 10:56
Key market opportunities in anesthesia and respiratory devices include technological advancements, regulatory developments, and growing demand for patient monitoring, ventilators, and disposable products. Companies can leverage innovations in ESG practices and sustainability trends to gain a competitive edge in expanding global markets. Anesthesia and Respiratory Devices Market Anesthesia and Respiratory Devices Market Dublin, Sept. 25, 2025 (GLOBE NEWSWIRE) -- The "Anesthesia and Respiratory De
Add These 4 GARP Stocks to Your Portfolio to Receive Handsome Returns
24.09.2025 13:32
The GARP strategy helps investors gain exposure to stocks that have solid prospects and are trading at a discount. GE, RMD, VRT and NFG are some such stocks.
ResMed's (NYSE:RMD) investors will be pleased with their respectable 66% return over the last five years
24.09.2025 13:00
When you buy and hold a stock for the long term, you definitely want it to provide a positive return. But more than...
Baxter Stock Slips Despite Latest Launch to Boost Patient Monitoring
18.09.2025 13:52
BAX launches FDA-cleared Connex 360 monitor, aiming to boost frontline care and streamline patient monitoring.
How Is ResMed's Stock Performance Compared to Other Healthcare Stocks?
15.09.2025 07:07
ResMed has significantly outperformed other healthcare stocks over the past year, and analysts remain bullish on the stock’s prospects.
Is it Worth Retaining ResMed Stock in Your Portfolio Now?
03.09.2025 13:51
RMD's Mask and Device sales fuel growth, but macro headwinds and fierce competition continue to challenge its performance.
3 Reasons Investors Watch ResMed (RMD)
28.08.2025 04:01
ResMed has had an impressive run over the past six months as its shares have beaten the S&P 500 by 11.9%. The stock now trades at $281.96, marking a 20.7% gain. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.